“…The genome of B. bovis was described in 2007 (Brayton et al, 2007) and since then some studies have been carried out to characterize genetic diversity. Some genes (sbp-2 (spherical body protein 2), sbp-4 (spherical body protein 4), trap (thrombospondin-related anonymous protein), msa-1 (merozoite surface antigen 1), msa-2b (merozoite surface antigen 2b), msa-2c (merozoite surface antigen 2c), Bv80 (or Bb-1, merozoite protein), 18S rRNA, acs-1 (acyl-CoA synthetase 1), ama-1 (apical membrane antigen 1), β-tub (tubulin beta chain), cp-2 (cysteine peptidase 2), p0 (ribosomal phosphoprotein) and rap-1a (rhoptry associated protein 1a) and also ITS region (internal transcribed spacer (Brown et al, 1996;Hilpertshauser et al, 2007;Mazuz et al, 2012;Ramos et al, 2012;Sivakumar et al, 2013;Combrink et al, 2014;Molad et al, 2014;Molad et al, 2015;Niu et al, 2015;Yokoyama et al, 2015;Tattiyapong et al, 2016;Matos et al, 2017;Mtshali & Mtshali, 2017;Rittipornlertrak et al, 2017;Gallego-Lopez et al, 2018)) pointed for the production of highly immunogenic proteins have been targets of these studies. However, it remains not elucidated which gene or which of these genes would be a good marker for genotyping studies regarding attenuation or virulent phenotypes.…”